Neurizon Therapeutics announces strong safety results in latest study
Drug candidate NUZ-001 has shown strong safety characteristics in its latest human…
Neurizon Therapeutics Limited (ASX:NUZ)
About Neurizon Therapeutics Limited
Key Information
NUZ In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 14/05/2025 | Neurizon to present at Annual ALS Drug Development Summit | 5.53MB | 6.0K |
| 06/05/2025 | Neurizon to present Q3 FY2025 Results | 1.57MB | 17K |
| 05/05/2025 | Price Sensitive PS Last Patient Successfully Completes Treatment in OLE Study | 669.76KB | 11K |
| 28/04/2025 | Price Sensitive PS Appendix 4C & Quarterly Update | 923.97KB | 10K |
| 24/04/2025 | Notice of Quarterly Shareholder Update Webinar | 175.77KB | 9.1K |
| 22/04/2025 | Appointment of Chief Financial Officer | 363.89KB | 6.8K |
| 17/04/2025 | Leadership team strengthened with strategic appointments | 197.75KB | 12K |
| 04/04/2025 | Price Sensitive PS NUZ-001 Promotes Survival in TDP-43 Challenged NSC-34 Cells | 6.91MB | 19K |